Furthermore, abnormal expression of some ferroptosis-related TP53 target genes has been identified in cancer cells, including downregulation of the proferroptotic gene SAT1 (99) and upregulation of the antiferroptotic gene CDKN1A/p21 (100), which contributes to inhibiting ferroptosis in cancer cells and maintaining their survival. This evidence concerns the gene SAT1 and cancer.